Objective: Gastric cancer is the second most common cause of cancer-related deaths. It is mostly seen between the ages of 50-70 years. In our study, we aimed to present our 11 years of experience about surgical treatment of gastric cancer. Method: In our medical faculty hospital between January 2000 and December 2010, a total of 504 patients, who operated with the diagnosis of gastric cancer, were analyzed retrospectively. Morbidity and mortality rate were evaluated according to type of operations and risk factors. Results: 182 of the patients (mean age 62.4 years) were female (36.1%) and 322 (63.9%) were male. The tumor location was antrum in the 202 (40.1%) patients, corpus in the 107 (21.2%) patients, cardia and fundus in the 195 (38.7%) patients. Distal subtotal gastrectomy was done 160 (%31.7) of the patients, total gastrectomy was done 204 (%40.5) of the patients and 140 (%27.8) of the patients were considered to be nonresectable because of reasons such as the liver metastasis, peritoneal dissemination and invasion of adjacent organs. Morbidity was found to be %17.6 (n=89) and early mortality rate was found as %5.5 (n=28), respectively. Conclusion: We found that gastric cancer patients are diagnosed at advanced stage in our region. Especially people who are at risk and have symptoms should be undertaken to screening programs such as endoscopy. In patients with gastric cancer, there is a relationship between advanced age, hypoalbuminemia, and serious co-morbidity with surgical mortality. AnahtarKelimeler: Mide Kanseri, cerrahit tedavi, mortalite.